Feasibility of Treating Irradiated Bone with Intramedullary Delivered Autologous Mesenchymal Stem Cells

Figure 2

Mesenchymal quality of the engrafted BMSCs and injection procedure. (a) flow cytometry data depicting several conventional surface antigens of mesenchymal cells (CD34−, CD44+, CD45−, and CD90+) prior to implantation (passage 4). (b) technique of intramedullary injection (left panel) and on the right panel, the arrow indicates the bandage on the surgical site after BMSC engraftment.

(a)

(b)